Results 101 to 110 of about 6,671 (111)

Mono‐galloyl glucose derivatives are potent poly(ADP‐ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP‐1‐dependent cell death

British Journal of Pharmacology, 2008
Laura Formentini, Stefano Menichetti
exaly  

PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion

FASEB Journal, 2005
Salvatore Cuzzocrea, Rosanna Di Paola, Tiziana Genovese   +2 more
exaly  

PARP and PARG Inhibitors—New Therapeutic Targets in Cancer Treatment

Pathology and Oncology Research, 2010
Ya-Lan Wang
exaly  

PARG1, a protein-tyrosine phosphatase-associated RhoGAP, as a putative Rap2 effector

Biochemical and Biophysical Research Communications, 2005
Masato Umikawa, Hiroshi Uezato, Ken-Ichi Kariya   +2 more
exaly  

PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancer

Proceedings of the National Academy of Sciences of the United States of America
Alan D'Andrea, , Geoffrey Shapiro
exaly  

PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy

Journal of Hepatology
Hui Li, Ye Qinghai, Peiyi Xie
exaly  

PARG inhibition induces nuclear aggregation of PARylated PARP1

Structure
Ranjit Bindra, Ranjini Sundaram, Sateja Paradkar   +2 more
exaly  

PARG Protein Regulation Roles in Drosophila Longevity Control

International Journal of Molecular Sciences
Alexei Tülin, Guillaume Bordet, Bordet Guillaume   +2 more
exaly  

Effect of silencing PARG in human colon carcinoma LoVo cells on the ability of HUVEC migration and proliferation

Cancer Gene Therapy, 2012
exaly  

Efficient synthesis of imidazo[1,5-a]pyridine sulfonamido derivative as a PARG inhibitor

Tetrahedron
Zhiqun Yu
exaly